XLV News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

XL

Volume

8.33M

Loading chart

XL

XLVState Street Health Care Select Sector SPDR ETF

XLV

Pay with—

Available Balance0.00

XL

AUM

N/A

Volume

8.33M

Yield

1.45%

Chart Earnings News About Dividends Insider Filings

Stock Market News for Oct 16, 2026Wall Street rallied on Thursday with all three major indexes closing in the green, driven by a rotation into defensive sectors like healthcare, materials, and financials. Investors shifted away from debt-sensitive AI and technology stocks as Treasury yields fell. The Dow Jones jumped 1.1%, the S&P 500 added 0.3%, and the Nasdaq gained 0.1%, while economic data showed mixed signals with jobless claims rising slightly and PPI inflation at 1.3%.Zacks Investment Research · Oct 16, 2026

Stock Market News for Oct 8, 2026U.S. stock markets closed higher on Wednesday with the Dow rising 0.7%, Nasdaq and S&P 500 each gaining 0.2%. Federal Reserve officials project another rate hike by end of 2026 but remain divided on timing amid economic uncertainty. Consumer credit growth fell short of expectations in August.Zacks Investment Research · Oct 8, 2026

Stock Market News for Oct 2, 2026U.S. stock markets ended Thursday's volatile session in positive territory as Treasury yields retreated from 24-year highs, boosting investor sentiment. The Dow, Nasdaq, and S&P 500 all gained modestly. Micron Technology reported exceptional fourth-quarter earnings with non-GAAP EPS surging 11-fold year-over-year, driven by strong AI demand and tight memory conditions. Economic data showed manufacturing activity remained in expansion territory while jobless claims fell below expectations.Zacks Investment Research · Oct 2, 2026

State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for InvestorsXLV and IXJ are two healthcare ETFs with different approaches: XLV focuses on 60 U.S. S&P 500 healthcare stocks with a low 0.08% expense ratio and stronger recent returns, while IXJ offers broader global diversification with 110 holdings across multiple countries but charges a higher 0.38% expense ratio. The choice depends on whether investors prioritize cost efficiency and domestic concentration or international diversification.The Motley Fool · Sep 13, 2026

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?The ALPS Medical Breakthroughs ETF (SBIO) is a passively managed healthcare ETF that tracks small-cap and mid-cap pharmaceutical and biotechnology stocks in Phase II or Phase III FDA clinical trials. With a 0.5% expense ratio, $243.54 million in assets, and 107 holdings, it has delivered 32.1% year-to-date returns and 82.83% over 12 months. However, it carries high risk with a beta of 0.74 and 30.54% standard deviation. The fund received a Zacks ETF Rank of 3 (Hold), with alternatives like VHT and XLV offering lower expense ratios.Zacks Investment Research · Sep 8, 2026

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.Zacks Investment Research · Aug 31, 2026

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?The article compares two healthcare sector ETFs: Vanguard Health Care ETF (VHT) with 423 holdings and State Street Health Care Select Sector SPDR ETF (XLV) with 60 holdings. While XLV has slightly lower expenses (0.08% vs 0.09%) and better 5-year returns, VHT outperforms on 1-year returns and offers broader diversification. The analysis recommends VHT for long-term investors due to superior recent performance and lower concentration risk.The Motley Fool · Aug 8, 2026

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?State Street's XLV healthcare ETF offers broader exposure with lower costs (0.08% expense ratio) and higher dividend yield (1.6%), delivering 30% more growth over five years with lower volatility. VanEck's BBH biotech ETF provides concentrated exposure to 25 biotech stocks with higher recent returns but greater risk, making XLV the better choice for long-term investors seeking defensive characteristics.The Motley Fool · Aug 5, 2026

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?XLV, a broad healthcare ETF, offers lower costs (0.08% expense ratio) and higher dividend yield (1.60%) with more stability, while IBBQ, a concentrated biotech ETF, delivered stronger one-year returns (45.52% vs 26.79%) but with significantly higher volatility and drawdown risk. The choice depends on investor risk tolerance and investment objectives.The Motley Fool · Aug 1, 2026

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?The State Street Health Care Select Sector SPDR ETF (XLV) and Fidelity MSCI Health Care Index ETF (FHLC) both offer low-cost healthcare exposure with identical 0.08% expense ratios. XLV focuses on 60 mega-cap healthcare stocks and has delivered stronger 5-year returns ($1,332 vs $1,276 on $1,000 invested), higher dividend yield (1.60% vs 1.30%), and greater liquidity with $41.7B in AUM. FHLC provides broader diversification with 365 holdings including mid and small-cap stocks. Over 10 years, both underperformed the S&P 500 significantly, with XLV returning 157% (9.9% CAGR) and FHLC returning 159% (10.0% CAGR) versus the S&P 500's 301% (14.9% CAGR).The Motley Fool · Jul 27, 2026

to start trading

XL

XLVState Street Health Care Select Sector SPDR ETF

XLV

Pay with—

Available Balance0.00

Your PositionYou don't own any XLV yet.

Related Tickers

Earnings

Dividends

Last · Sep 21Quarterly

Amount$0.64

Yield1.44%

Annual$2.55